{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:19:10Z","timestamp":1791357550065,"version":"4.3.1"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Bipolar disorder is a mood disorder which requires complex treatment. Current treatment guidelines are based on the results of published randomized clinical trials and meta-analyses which may not accurately reflect everyday clinical practice. This multi-national, multi-centre, observational cohort study describes clinical management and clinical outcomes related to bipolar disorder in real-life settings, assesses between-country variability and identifies factors associated with clinical outcomes. Adults from 10 countries in Europe and South America who experienced at least one mood episode in the preceding 12 months were included. Overall, 2896 patients were included in the analyses and followed for at least 9 months across a retrospective and prospective study phase. Main outcome measures were the number and incidence rate of mood episodes (relapses and recurrences) and healthcare resource use including pharmacological treatments. Relapses and recurrences were reported in 18.2 and 40.5% of patients, respectively; however, the reported incidence rate of relapses was higher than that of recurrences [1.562 per person-year (95% CI 1.465\u20131.664) vs. 0.691 per person-year (95% CI 0.657\u20130.726)]. Medication use was high during all episode types and euthymia; the percentage of patients receiving no medication ranged from 11.0% in mania to 6.1% in euthymia. Antipsychotics were the most commonly prescribed drug class in all disease phases except for patients with depression, where antidepressants were more frequently prescribed. Visits to the psychiatrist were the most frequently used healthcare resource. These results provide a description of treatment patterns for bipolar disorder across different countries and indicate factors related to relapse and recurrence.<\/jats:p>","DOI":"10.1017\/s1461145713000278","type":"journal-article","created":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T06:10:21Z","timestamp":1368425421000},"page":"1719-1732","source":"Crossref","is-referenced-by-count":79,"title":["Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd)"],"prefix":"10.1093","volume":"16","author":[{"given":"Eduard","family":"Vieta","sequence":"first","affiliation":[{"name":"Bipolar Disorders Program, Hospital Cl\u00ednic, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens M.","family":"Langosch","sequence":"additional","affiliation":[{"name":"Bethanien Hospital for Psychiatry, Psychosomatics, and Psychotherapy, Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Figueira","sequence":"additional","affiliation":[{"name":"Psychiatric Department, Hospital Santa Maria, Faculty of Medicine, University of Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Souery","sequence":"additional","affiliation":[{"name":"Centre Europ\u00e9en de Psychologie M\u00e9dicale\/Psy-Pluriel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Blasco-Colmenares","sequence":"additional","affiliation":[{"name":"Johns Hopkins University Institution, SOM DOM Cardiology, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Medina","sequence":"additional","affiliation":[{"name":"Medical Department, AstraZeneca Pharmaceuticals, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Moreno-Manzanaro","sequence":"additional","affiliation":[{"name":"Medical Department, AstraZeneca Pharmaceuticals, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Quintiles, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bellivier","sequence":"additional","affiliation":[{"name":"AP-HP, GH Saint-Louis-Lariboisi\u00e8re-Fernand Widal, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,9,1]]},"reference":[{"key":"2019101113495758500_ref1","unstructured":"American Psychiatric Association\n           (2012) Practice guideline for the treatment of patients with bipolar disorder. Second edition. http:\/\/psychiatryonline.org\/data\/Books\/prac\/Bipolar2e_Inactivated_04-16-09.pdf. Retrieved 27 Feb 2012."},{"key":"2019101113495758500_ref2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/archgenpsychiatry.2011.87","article-title":"Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study","volume":"68","author":"Angst","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"2019101113495758500_ref3","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1176\/appi.ps.59.10.1175","article-title":"Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence","volume":"59","author":"Baldessarini","year":"2008","journal-title":"Psychiatr Serv"},{"key":"2019101113495758500_ref4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1176\/appi.ps.58.1.85","article-title":"Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders","volume":"58","author":"Baldessarini","year":"2007","journal-title":"Psychiatr Serv"},{"key":"2019101113495758500_ref5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.wpsyc.2012.01.006","article-title":"Age at onset vs. family history and clinical outcomes in 1665 international bipolar-I disorder patients","volume":"11","author":"Baldessarini","year":"2012","journal-title":"World Psychiatry"},{"key":"2019101113495758500_ref6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1399-5618.2011.00926.x","article-title":"Suicidal attempts in bipolar disorder: results from an observational study (EMBLEM)","volume":"13","author":"Bellivier","year":"2011","journal-title":"Bipolar Disord"},{"key":"2019101113495758500_ref7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.4088\/JCP.v61n0802","article-title":"Clinical factors associated with treatment noncompliance in euthymic bipolar patients","volume":"61","author":"Colom","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"2019101113495758500_ref8","unstructured":"Crismon\n              ML\n            \n            \n              Argo\n              TR\n            \n            \n              Bendele\n              SD\n            \n            \n              Suppes\n              T\n            \n           (2012). Bipolar Disorder Algorithms. Texas Medication Algorithm Project 2007. http:\/\/www.pbhcare.org\/pubdocs\/upload\/documents\/TIMABDman2007.pdf. Retrieved 27 Feb 2012."},{"key":"2019101113495758500_ref9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1017\/S1461145709990344","article-title":"Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis","volume":"13","author":"Cruz","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"2019101113495758500_ref10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jad.2012.03.009","article-title":"Predictors of recurrence in bipolar disorders in Spain (PREBIS study data)","volume":"141","author":"de Dios","year":"2012","journal-title":"J Affect Disord"},{"key":"2019101113495758500_ref11","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1017\/S0033291799002810","article-title":"Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness","volume":"30","author":"Denicoff","year":"2000","journal-title":"Psychol Med"},{"key":"2019101113495758500_ref12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jad.2011.04.036","article-title":"Suicide and suicide attempts in the systematic treatment enhancement program for bipolar disorder (STEP-BD)","volume":"133","author":"Dennehy","year":"2011","journal-title":"J Affect Disord"},{"key":"2019101113495758500_ref13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1744-859X-10-8","article-title":"Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?","volume":"10","author":"Fountoulakis","year":"2011","journal-title":"Ann Gen Psychiatry"},{"key":"2019101113495758500_ref14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1034\/j.1399-5618.2003.00028.x","article-title":"The comorbidity of bipolar disorder and axis II personality disorders: prevalence and clinical correlates","volume":"5","author":"George","year":"2003","journal-title":"Bipolar Disord"},{"key":"2019101113495758500_ref15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1600-0447.2012.01882.x","article-title":"Anxiety as a marker of severity in acute mania","volume":"126","author":"Gonz\u00e1lez-Pinto","year":"2012","journal-title":"Acta Psychiatr Scand"},{"key":"2019101113495758500_ref16","first-page":"1","article-title":"Patterns of pharmacological maintenance treatment in a community mental health services bipolar disorder cohort study (SIN-DEPRES)","volume":"27","author":"Grande","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"2019101113495758500_ref17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/15622970902823202","article-title":"The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania","volume":"10","author":"Grunze","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"2019101113495758500_ref18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/15622970903555881","article-title":"The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression","volume":"11","author":"Grunze","year":"2010","journal-title":"World J Biol Psychiatry"},{"key":"2019101113495758500_ref19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3109\/15622975.2013.770551","article-title":"The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2013 on the long-term treatment of bipolar disorder","volume":"14","author":"Grunze","year":"2013","journal-title":"World J Biol Psychiatry"},{"key":"2019101113495758500_ref20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1600-0447.2004.00403.x","article-title":"The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands","volume":"110","author":"Hakkaart-van Roijen","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"2019101113495758500_ref21","first-page":"7","article-title":"Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening","volume":"40","author":"Hirschfeld","year":"2007","journal-title":"Psychopharmacol Bull"},{"key":"2019101113495758500_ref22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","article-title":"A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder","volume":"60","author":"Judd","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"2019101113495758500_ref23","first-page":"631","article-title":"Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population","volume":"14","author":"Kamat","year":"2008","journal-title":"J Manag Care Pharm"},{"issue":"Spec. No. 6","key":"2019101113495758500_ref24","first-page":"33","article-title":"Anxious-excited depression: a mixed affective syndrome","volume":"21","author":"Koukopoulos","year":"1995","journal-title":"Encephale"},{"key":"2019101113495758500_ref25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1192\/bjp.bp.109.067843","article-title":"Rapid-cycling bipolar disorder: cross-national community study","volume":"196","author":"Lee","year":"2010","journal-title":"Br J Psychiatry"},{"key":"2019101113495758500_ref26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1399-5618.2006.00355.x","article-title":"Anxiety disorders and bipolar disorder: a review","volume":"8","author":"McIntyre","year":"2006","journal-title":"Bipolar Disord"},{"key":"2019101113495758500_ref27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1399-5618.2010.00810.x","article-title":"A prospective latent analyses study of psychiatric comorbidity of DSM-IV bipolar I and II disorders","volume":"12","author":"Mantere","year":"2010","journal-title":"Bipolar Disord"},{"key":"2019101113495758500_ref28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1017\/S0033291703001636","article-title":"Twelve-month prevalence and disability of DSM-IV bipolar disorder in an Australian general population survey","volume":"34","author":"Mitchell","year":"2004","journal-title":"Psychol Med"},{"key":"2019101113495758500_ref29","unstructured":"National Institute for Health and Clinical Excellence\n           (2006). Bipolar disorder - The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. NICE Clinical guideline 38. http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG38niceguideline.pdf. Retrieved 27 Feb 2012."},{"key":"2019101113495758500_ref30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000314307","article-title":"Lithium: still a cornerstone in the long-term treatment in bipolar disorder?","volume":"62","author":"Nivoli","year":"2010","journal-title":"Neuropsychobiology"},{"key":"2019101113495758500_ref31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jad.2010.05.018","article-title":"New treatment guidelines for acute bipolar depression: a systematic review","volume":"129","author":"Nivoli","year":"2011","journal-title":"J Affect Disord"},{"key":"2019101113495758500_ref32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jad.2011.10.015","article-title":"New treatment guidelines for acute bipolar mania: a critical review","volume":"140","author":"Nivoli","year":"2012","journal-title":"J Affect Disord"},{"key":"2019101113495758500_ref33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1176\/appi.ajp.2009.09020299","article-title":"Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the systematic treatment enhancement program for bipolar disorder (STEP-BD)","volume":"167","author":"Ostacher","year":"2010","journal-title":"Am J Psychiatry"},{"key":"2019101113495758500_ref34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.euroneuro.2010.10.002","article-title":"Factors associated with initial treatment response with antidepressants in bipolar disorder","volume":"21","author":"Pacchiarotti","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"2019101113495758500_ref35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1176\/appi.ajp.163.2.217","article-title":"Predictors of recurrence in bipolar disorder: primary outcomes from the systematic treatment enhancement program for bipolar disorder (STEP-BD)","volume":"163","author":"Perlis","year":"2006","journal-title":"Am J Psychiatry"},{"key":"2019101113495758500_ref36","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1038\/npp.2010.122","article-title":"Transition to mania during treatment of bipolar depression","volume":"35","author":"Perlis","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"2019101113495758500_ref37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.euroneuro.2005.04.011","article-title":"Prevalence and burden of bipolar disorders in European countries","volume":"15","author":"Pini","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"2019101113495758500_ref38","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1586\/ern.09.87","article-title":"Myth of evidence-based medicine for bipolar disorder","volume":"9","author":"Post","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"2019101113495758500_ref39","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.4088\/JCP.v68n1007","article-title":"Relevance of family history of suicide in the long-term outcome of bipolar disorders","volume":"68","author":"Romero","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"2019101113495758500_ref40","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.4088\/JCP.09m05026gre","article-title":"Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study","volume":"71","author":"Rosa","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"2019101113495758500_ref41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1755-5949.2009.00089.x","article-title":"Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials","volume":"17","author":"Rosa","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"2019101113495758500_ref42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1399-5618.2009.00777.x","article-title":"Ten-year diagnostic consistency of bipolar disorder in a first-admission sample","volume":"12","author":"Ruggero","year":"2010","journal-title":"Bipolar Disord"},{"key":"2019101113495758500_ref43","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1192\/bjp.bp.109.076489","article-title":"Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders","volume":"197","author":"Saarni","year":"2010","journal-title":"Br J Psychiatry"},{"key":"2019101113495758500_ref44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the clinical global impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Res"},{"key":"2019101113495758500_ref45","doi-asserted-by":"publisher","first-page":"749","DOI":"10.4088\/JCP.v69n0508","article-title":"Diagnosis of unipolar depression following initial identification of bipolar disorder: a common and costly misdiagnosis","volume":"69","author":"Stensland","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"2019101113495758500_ref46","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1749-6632.2009.05146.x","article-title":"The strong relationship between bipolar and substance-use disorder","volume":"1187","author":"Swann","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"2019101113495758500_ref47","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1600-0447.2007.01066.x","article-title":"Suicidal risks among 2826 Sardinian major affective disorder patients","volume":"116","author":"Tondo","year":"2007","journal-title":"Acta Psychiatr Scand"},{"key":"2019101113495758500_ref48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jad.2012.01.027","article-title":"Bipolar depression: clinical correlates of receiving antidepressants","volume":"139","author":"Undurraga","year":"2012","journal-title":"J Affect Disord"},{"key":"2019101113495758500_ref49","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1399-5618.2011.00908.x","article-title":"Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients","volume":"13","author":"Valent\u00ed","year":"2011","journal-title":"Bipolar Disord"},{"key":"2019101113495758500_ref50","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.4088\/JCP.11m07166","article-title":"Risk factors for antidepressant-related switch to mania","volume":"73","author":"Valent\u00ed","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"2019101113495758500_ref51","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.4088\/JCP.v66n1116","article-title":"Suicidal ideation and attempts in bipolar I and II disorders","volume":"66","author":"Valtonen","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"2019101113495758500_ref52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-244X-11-58","article-title":"Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd study)","volume":"11","author":"Vieta","year":"2011","journal-title":"BMC Psychiatry"},{"key":"2019101113495758500_ref53","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1017\/S1461145711000885","article-title":"Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials","volume":"14","author":"Vieta","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"2019101113495758500_ref54","unstructured":"World Health Organisation\n           (2012a). World Health Report 2001: Mental Health - New Understanding, New Hope. http:\/\/www.who.int\/whr\/2001\/en\/whr01_en.pdf. Retrieved 27 Feb 2012."},{"key":"2019101113495758500_ref55","unstructured":"World Health Organisation\n           (2012b) The global burden of disease: 2004 update. http:\/\/www.who.int\/healthinfo\/global_burden_disease\/GBD_report_2004update_full.pdf. Retrieved 27 Feb 2012."},{"key":"2019101113495758500_ref56","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disord"},{"key":"2019101113495758500_ref57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0165-0327(93)90118-4","article-title":"Anxious and non-anxious bipolar disorder","volume":"29","author":"Young","year":"1993","journal-title":"J Affect Disord"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/16\/8\/1719\/30135213\/16-8-1719.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/16\/8\/1719\/30135213\/16-8-1719.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T16:50:25Z","timestamp":1570812625000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/16\/8\/1719\/815178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,1]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,9,1]]}},"URL":"https:\/\/doi.org\/10.1017\/s1461145713000278","relation":{},"ISSN":["1469-5111","1461-1457"],"issn-type":[{"value":"1469-5111","type":"electronic"},{"value":"1461-1457","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,9]]},"published":{"date-parts":[[2013,9,1]]}}}